K. Töpfer

发表

Tumor Evasion from T Cell Surveillance

G. Schackert, A. Temme, M. Bachmann, 2011, Journal of biomedicine & biotechnology.

DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy

G. Schackert, D. Lindemann, A. Temme, 2015, The Journal of Immunology.

Immunoinhibitory Pathway Aged Mice through Blockade of an T Cell Responses in + Virus-Specific CD8 Augmentation of Primary Influenza A

H. Ertl, Hong-gang Yu, Dongming Zhou, 2010 .

Augmentation of Primary Influenza A Virus-Specific CD8+ T Cell Responses in Aged Mice through Blockade of an Immunoinhibitory Pathway

H. Ertl, Hong-gang Yu, M. Lasaro, 2010, The Journal of Immunology.

ImmunotherapyReceptor for NK Cell Tumor DAP12-Based Activating Chimeric Antigen

G. Schackert, D. Lindemann, M. Cartellieri, 2015 .

Cytotoxic response of human regulatory T cells upon T-cell receptor-mediated activation: a matter of purity

G. Ehninger, A. Temme, M. Bachmann, 2014, Blood Cancer Journal.

Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies

K. Kretschmer, G. Ehninger, A. Temme, 2012, The Journal of Immunology.

This information is current as T Cells + and CD 4 + Tumor Cells by CD 8 Prostate Stem Cell Antigen-Expressing Bispecific Antibodies Mediate Killing of Novel Humanized and Highly Efficient

G. Ehninger, D. Lindemann, A. Temme, 2012 .

Single-Chain Bispecific Antibodies Retargeting of Human Regulatory T Cells by

K. Kretschmer, G. Ehninger, A. Temme, 2011 .

Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome.

H. Ertl, Xiangyang Zhou, K. High, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody‐based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells

G. Ehninger, A. Temme, M. Bachmann, 2014, The Prostate.

Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1&agr;-secreting Glioblastoma

I. Pastan, G. Schackert, A. Temme, 2015, Journal of immunotherapy.

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53

E. Schröck, B. Klink, G. Schackert, 2014, Molecular Cancer.

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo

G. Schackert, A. Aigner, A. Temme, 2011, Neuro-oncology.

Novel Humanized and Highly Efficient Bispecific Antibodies Mediate Killing of Prostate Stem Cell Antigen-Expressing Tumor Cells by CD8+ and CD4+ T Cells

G. Ehninger, D. Lindemann, A. Temme, 2012, The Journal of Immunology.

Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53

E. Schröck, B. Klink, G. Schackert, 2014, Molecular Cancer.

Redirectionof CD4þ andCD8þTlymphocytesvia aNovel Antibody-BasedModularTargeting SystemTriggers Eff|cient

G. Ehninger, A. Temme, M. Bachmann, 2014 .

A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells

G. Ehninger, D. Lindemann, A. Temme, 2014, PloS one.